Concepedia

Francesco Paolo Tambaro

FP

Statistics

Publications

17

Citations

1.1K

H-Index

15

Active since

2007

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Naples Federico II

Huntsman Cancer Institute

Azienda di Rilievo Nazionale ed Alta Specializzazione

Institute of Genetics and Biophysics

Francesco Paolo Tambaro is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hematology.

ORCID

Publications per year

2007–2021

17

Publications

17

Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia

Francesco Paolo Tambaro, Harjeet Singh, Emily Jones et al. · Leukemia · 2021 · 181 citations · Full text

, , +14

c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer

Angela Nebbioso, Vincenzo Carafa, Mariarosaria Conte et al. · Clinical Cancer Research · 2016 · 174 citations · Full text

, , +17

Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Guillermo Garcia‐Manero, Francesco Paolo Tambaro, N. Bekele et al. · Journal of Clinical Oncology · 2012 · 164 citations · Full text

, , +15

Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL

Paolo Strati, Michael J. Keating, Susan O’Brien et al. · Blood · 2014 · 143 citations

, , +13

The Combination of a Histone Deacetylase Inhibitor with the Bcl-2 Homology Domain-3 Mimetic GX15-070 Has Synergistic Antileukemia Activity by Activating Both Apoptosis and Autophagy

Yue Wei, Tapan M. Kadia, Weigang Tong et al. · Clinical Cancer Research · 2010 · 67 citations · Full text

, , +11

1–5 of 17